| Industry | Status | Date | Ticker(s) | issuer(s) | MO | SP | FI | Size (M) | Ranking | TNR | Call | MTY | Coupon | Leads | product | Region | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HLTH | PRCD | Aug 24, 2026 | AZN | AstraZeneca Finance LLC | A1 | A+ | - | €700 | Sr. Unsecured | 3.50 | - | Mar-30 | 3.402% | IGC | EMEA | ||||
HLTH | PRCD | Aug 24, 2026 | AZN | AstraZeneca Finance LLC | A1 | A+ | - | €600 | Sr. Unsecured | 6.00 | - | Sep-32 | 3.652% | IGC | EMEA | ||||
HLTH | PRCD | Aug 24, 2026 | AZN | AstraZeneca Finance LLC | A1 | A+ | - | €500 | Sr. Unsecured | 9.00 | - | Sep-35 | 3.923% | IGC | EMEA | ||||
HLTH | PRCD | Aug 24, 2026 | AZN | AstraZeneca Finance LLC | A1 | A+ | - | €750 | Sr. Unsecured | 12.00 | - | Sep-38 | 4.169% | IGC | EMEA | ||||
HLTH | PRCD | Feb 25, 2026 | AZN | AstraZeneca Finance LLC | A1 | A+ | - | $650 | Sr. Unsecured | 5.00 | - | Mar-31 | 4.00% | IGC | EMEA | ||||
HLTH | PRCD | Feb 25, 2026 | AZN | AstraZeneca Finance LLC | A1 | A+ | - | $600 | Sr. Unsecured | 7.00 | - | Mar-33 | 4.30% | IGC | EMEA | ||||
HLTH | PRCD | Feb 25, 2026 | AZN | AstraZeneca Finance LLC | A1 | A+ | - | $750 | Sr. Unsecured | 10.00 | - | Mar-36 | 4.60% | IGC | EMEA | ||||
HLTH | PRCD | Jul 29, 2024 | AZN | AstraZeneca Finance LLC | A2 | A+ | - | €650 | Sr. Unsecured | 6.00 | - | Aug-30 | 3.121% | IGC | EMEA | ||||
HLTH | PRCD | Jul 29, 2024 | AZN | AstraZeneca Finance LLC | A2 | A+ | - | €750 | Sr. Unsecured | 9.00 | - | Aug-33 | 3.278% | IGC | EMEA | ||||
HLTH | PRCD | Feb 21, 2024 | AZN | AstraZeneca Finance LLC | A2 | A | - | $1,250 | Sr. Unsecured | 3.00 | - | Feb-27 | 4.800% | IGC | EMEA |